Ad is loading...
MYO
Price
$4.66
Change
-$0.19 (-3.92%)
Updated
Nov 15 closing price
109 days until earnings call
PLSE
Price
$16.64
Change
-$0.47 (-2.75%)
Updated
Nov 15 closing price
130 days until earnings call
Ad is loading...

MYO vs PLSE

Header iconMYO vs PLSE Comparison
Open Charts MYO vs PLSEBanner chart's image
Myomo
Price$4.66
Change-$0.19 (-3.92%)
Volume$193.07K
CapitalizationN/A
Pulse Biosciences
Price$16.64
Change-$0.47 (-2.75%)
Volume$91.51K
CapitalizationN/A
MYO vs PLSE Comparison Chart
Loading...
MYO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PLSE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
MYO vs. PLSE commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MYO is a Sell and PLSE is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (MYO: $4.66 vs. PLSE: $16.64)
Brand notoriety: MYO and PLSE are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: MYO: 129% vs. PLSE: 55%
Market capitalization -- MYO: $93.15M vs. PLSE: $481.01M
MYO [@Medical Specialties] is valued at $93.15M. PLSE’s [@Medical Specialties] market capitalization is $481.01M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MYO’s FA Score shows that 0 FA rating(s) are green whilePLSE’s FA Score has 0 green FA rating(s).

  • MYO’s FA Score: 0 green, 5 red.
  • PLSE’s FA Score: 0 green, 5 red.
According to our system of comparison, both MYO and PLSE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MYO’s TA Score shows that 5 TA indicator(s) are bullish while PLSE’s TA Score has 3 bullish TA indicator(s).

  • MYO’s TA Score: 5 bullish, 5 bearish.
  • PLSE’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, MYO is a better buy in the short-term than PLSE.

Price Growth

MYO (@Medical Specialties) experienced а -3.12% price change this week, while PLSE (@Medical Specialties) price change was -16.26% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.23%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -6.14%.

Reported Earning Dates

MYO is expected to report earnings on Mar 06, 2025.

PLSE is expected to report earnings on Mar 27, 2025.

Industries' Descriptions

@Medical Specialties (-4.23% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PLSE($481M) has a higher market cap than MYO($93.2M). PLSE YTD gains are higher at: 35.948 vs. MYO (-6.986). MYO has higher annual earnings (EBITDA): -7.71M vs. PLSE (-42.37M). PLSE has more cash in the bank: 44.4M vs. MYO (8.87M). MYO has less debt than PLSE: MYO (601K) vs PLSE (9.14M). MYO has higher revenues than PLSE: MYO (19.2M) vs PLSE (0).
MYOPLSEMYO / PLSE
Capitalization93.2M481M19%
EBITDA-7.71M-42.37M18%
Gain YTD-6.98635.948-19%
P/E RatioN/AN/A-
Revenue19.2M0-
Total Cash8.87M44.4M20%
Total Debt601K9.14M7%
FUNDAMENTALS RATINGS
MYO vs PLSE: Fundamental Ratings
MYO
PLSE
OUTLOOK RATING
1..100
414
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
61
Fair valued
PROFIT vs RISK RATING
1..100
10093
SMR RATING
1..100
9796
PRICE GROWTH RATING
1..100
3837
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MYO's Valuation (58) in the Medical Distributors industry is in the same range as PLSE (61) in the Medical Specialties industry. This means that MYO’s stock grew similarly to PLSE’s over the last 12 months.

PLSE's Profit vs Risk Rating (93) in the Medical Specialties industry is in the same range as MYO (100) in the Medical Distributors industry. This means that PLSE’s stock grew similarly to MYO’s over the last 12 months.

PLSE's SMR Rating (96) in the Medical Specialties industry is in the same range as MYO (97) in the Medical Distributors industry. This means that PLSE’s stock grew similarly to MYO’s over the last 12 months.

PLSE's Price Growth Rating (37) in the Medical Specialties industry is in the same range as MYO (38) in the Medical Distributors industry. This means that PLSE’s stock grew similarly to MYO’s over the last 12 months.

PLSE's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as MYO (100) in the Medical Distributors industry. This means that PLSE’s stock grew similarly to MYO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MYOPLSE
RSI
ODDS (%)
Bearish Trend 3 days ago
86%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
78%
Momentum
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
84%
MACD
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 12 days ago
85%
Declines
ODDS (%)
Bearish Trend about 1 month ago
89%
Bearish Trend 3 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
85%
Aroon
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
89%
View a ticker or compare two or three
Ad is loading...
MYO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PLSE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRQSF0.200.02
+9.53%
Borqs Technologies, Inc.
EDNMY15.000.30
+2.04%
Edenred Malakoff
MAIFF0.23N/A
+1.56%
Minera Alamos, Inc.
KIGRY9.12N/A
-0.02%
KION GROUP AG
CNSWF3140.00-86.79
-2.69%
Constellation Software, Inc.

MYO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MYO has been loosely correlated with CTKB. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if MYO jumps, then CTKB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MYO
1D Price
Change %
MYO100%
-3.92%
CTKB - MYO
34%
Loosely correlated
-7.32%
RDNT - MYO
32%
Poorly correlated
-1.83%
AZTA - MYO
30%
Poorly correlated
-2.62%
CERS - MYO
30%
Poorly correlated
-4.44%
PLSE - MYO
30%
Poorly correlated
-2.75%
More

PLSE and

Correlation & Price change

A.I.dvisor tells us that PLSE and CERS have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PLSE and CERS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLSE
1D Price
Change %
PLSE100%
-2.75%
CERS - PLSE
31%
Poorly correlated
-4.44%
NEOG - PLSE
30%
Poorly correlated
-0.27%
MYO - PLSE
30%
Poorly correlated
-3.92%
MASS - PLSE
29%
Poorly correlated
+0.42%
IRMD - PLSE
29%
Poorly correlated
-3.56%
More